403 related articles for article (PubMed ID: 30857854)
1. Evaluation of efficacy of pancreatic juice cytology for risk classification according to international consensus guidelines in patients with intraductal papillary mucinous neoplasm; a retrospective study.
Yamakawa K; Masuda A; Nakagawa T; Shiomi H; Toyama H; Takenaka M; Sakai A; Kobayashi T; Tsujimae M; Ashina S; Yamada Y; Tanaka T; Tanaka S; Nakano R; Sato Y; Ikegawa T; Kurosawa M; Fujigaki S; Kutsumi H; Itoh T; Fukumoto T; Kodama Y
Pancreatology; 2019 Apr; 19(3):424-428. PubMed ID: 30857854
[TBL] [Abstract][Full Text] [Related]
2. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients.
Yoshioka T; Shigekawa M; Yamai T; Suda T; Kegasawa T; Iwahashi K; Ikezawa K; Sakamori R; Yakushijin T; Hiramatsu N; Tatsumi T; Takehara T
Pancreatology; 2016; 16(6):1020-1027. PubMed ID: 27567445
[TBL] [Abstract][Full Text] [Related]
3. Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012.
Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Aso T; Miyasaka Y; Ueda J; Takahata S; Osoegawa T; Igarashi H; Ito T; Ushijima Y; Ookubo F; Oda Y; Mizumoto K; Tanaka M
World J Surg; 2014 Nov; 38(11):2994-3001. PubMed ID: 25037612
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic juice cytology with immunohistochemistry to detect malignancy and histologic subtypes in patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Koshita S; Noda Y; Ito K; Kanno Y; Ogawa T; Masu K; Masaki Y; Horaguchi J; Oikawa M; Tsuchiya T; Sawai T; Uzuki M; Fujishima F
Gastrointest Endosc; 2017 May; 85(5):1036-1046. PubMed ID: 27756613
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm.
Miyamoto K; Matsumoto K; Kato H; Yoshida R; Umeda Y; Inoue H; Tanaka T; Matsumi A; Saragai Y; Fujii Y; Yamazaki T; Uchida D; Tomoda T; Horiguchi S; Yagi T; Okada H
BMC Gastroenterol; 2020 Sep; 20(1):319. PubMed ID: 32993498
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
[TBL] [Abstract][Full Text] [Related]
7. The role of pancreatic juice cytology in the diagnosis of pancreatic intraductal papillary mucinous neoplasm.
Tag-Adeen M; Ozawa E; Ogihara K; Iwatsu S; Akazawa Y; Ohnita K; Adachi T; Sumida Y; Nakao K
Rev Esp Enferm Dig; 2018 Dec; 110(12):775-781. PubMed ID: 30168338
[TBL] [Abstract][Full Text] [Related]
8. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
Hara T; Ikebe D; Odaka A; Sudo K; Nakamura K; Yamamoto H; Itami M; Hirata T; Kashimura J; Yamaguchi T
Ann Surg; 2013 Jun; 257(6):1103-11. PubMed ID: 23364699
[TBL] [Abstract][Full Text] [Related]
9. Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?
Nagayama R; Ueki T; Shimizu Y; Hijioka S; Nakamura M; Kitano M; Hara K; Masamune A; Kin T; Hanada K; Koshita S; Yamada R; Takenaka M; Itoi T; Yanagisawa A; Otuka T; Hirono S; Kanno A; Ideno N; Kuwahara T; Shimizu A; Kamata K; Asai Y; Takeyama Y
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):183-192. PubMed ID: 38084510
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic juice cytology in IPMN of the pancreas.
Yamaguchi K; Nakamura M; Shirahane K; Kawamoto M; Konomi H; Ohta M; Tanaka M
Pancreatology; 2005; 5(4-5):416-21; discussion 421. PubMed ID: 15985766
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Pancreatic Juice Cytology with Synthetic Secretin in Diagnosing Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Takeda Y; Matsumoto K; Onoyama T; Yamashita T; Koda H; Hamamoto W; Sakamoto Y; Shimosaka T; Kawahara S; Horie Y; Isomoto H
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328297
[TBL] [Abstract][Full Text] [Related]
13. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
[TBL] [Abstract][Full Text] [Related]
14. Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas.
Harada R; Kawamoto H; Fukatsu H; Kato H; Hirao K; Kurihara N; Mizuno O; Ogawa T; Ishida E; Okada H; Yamamoto K; Yamamoto H
Pancreas; 2010 Apr; 39(3):340-4. PubMed ID: 19823100
[TBL] [Abstract][Full Text] [Related]
15. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
16. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 2012 Fukuoka Consensus Guideline for Intraductal Papillary Mucinous Neoplasm of the Pancreas From a Single Institution Experience.
Yu S; Takasu N; Watanabe T; Fukumoto T; Okazaki S; Tezuka K; Sugawara S; Hirai I; Kimura W
Pancreas; 2017 Aug; 46(7):936-942. PubMed ID: 28697135
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of endoscopic retrograde cholangiopancreatography-based cytology for distinguishing malignant and benign intraductal papillary mucinous neoplasm: systematic review and meta-analysis.
Suzuki R; Thosani N; Annangi S; Komarraju A; Irisawa A; Ohira H; Obara K; Fleming JB; Guha S; Bhutani MS
Dig Endosc; 2014 Jul; 26(4):586-93. PubMed ID: 24450356
[TBL] [Abstract][Full Text] [Related]
19. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Seo N; Byun JH; Kim JH; Kim HJ; Lee SS; Song KB; Kim SC; Han DJ; Hong SM; Lee MG
Ann Surg; 2016 Mar; 263(3):557-64. PubMed ID: 25822687
[TBL] [Abstract][Full Text] [Related]
20. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
